Form 4: Merck Executive Reports Stock Transactions
Statement of Changes in Beneficial Ownership
Dalton E. Smart III, SVP Fin. - Global Controller at Merck & Co., Inc., reported transactions involving common stock and restricted stock units.
Summary
- Dalton E. Smart III, SVP Fin. - Global Controller for Merck & Co., Inc., has reported transactions related to company stock.
- On May 2, 2026, 383 shares of common stock were acquired at a price of $112.16 per share.
- Following this transaction, 9,520.315 shares of common stock are beneficially owned directly.
- Additionally, 132 shares of common stock were disposed of at a price of $112.16 per share, resulting in 9,388.315 shares beneficially owned directly.
- The filing also details a transaction involving 383 Restricted Stock Units (RSUs) on May 2, 2026.
- These RSUs represent a contingent right to receive one share of Merck & Co., Inc. common stock.
- The RSUs vest and are distributed in three equal installments on May 2, 2024, May 2, 2025, and May 2, 2026.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider stock transactions and compensation vesting, without significant positive or negative financial news.
Positives
- Acquisition of 383 shares of common stock at a price of $112.16, indicating continued investment or compensation.
- Vesting of restricted stock units, which is a common form of executive compensation and aligns management interests with shareholders.
Negatives
- Disposal of 132 shares of common stock at a price of $112.16, which could be interpreted as a sale of holdings.
Future Outlook
The Restricted Stock Units vest and are distributed in three equal installments on May 2, 2024, May 2, 2025, and May 2, 2026, indicating future potential share issuances to the reporting person.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions at publicly traded companies like Merck & Co., Inc., providing transparency into executive stock dealings.
Stakeholder Impact
- Shareholders: Increased transparency into executive stock ownership and transactions.
- Employees: Vesting of RSUs indicates continued employee compensation and potential for increased shareholding.
Next Steps
- Continued vesting and distribution of Restricted Stock Units on May 2, 2024, May 2, 2025, and May 2, 2026.
Key Dates
| Date | Description |
|---|---|
| 05/02/2026 | Earliest transaction date reported, and date of common stock acquisition and RSU transaction. |
| 05/02/2024 | First vesting installment date for Restricted Stock Units. |
| 05/02/2025 | Second vesting installment date for Restricted Stock Units. |
| 05/02/2026 | Third and final vesting installment date for Restricted Stock Units. |
| 05/05/2026 | Date the statement was signed. |
Keywords
Merck & Co., Inc., MRK, Form 4, Stock Transaction, Insider Trading, Executive Compensation, Restricted Stock Units, Beneficial Ownership, Dalton E. Smart III
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.